# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA619110 | A | At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for MRT | Mus musculus | 1 | organism-based format | Scientific Literature | ||
2. | ALA619262 | F | In vitro antitumor activity against A2780 human ovarian carcinoma at 7.5 mg/kg i.p. /qd x7 | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
3. | ALA619370 | A | At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for T max | Mus musculus | 2 | organism-based format | Scientific Literature | ||
4. | ALA621810 | A | At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for area under curve (AUCtot) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
5. | ALA623508 | A | At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for Cmax | Mus musculus | 3 | organism-based format | Scientific Literature | ||
6. | ALA621781 | F | Cytotoxic activity against A2780 human ovarian carcinoma cell line | Homo sapiens | 18 | cell-based format | Scientific Literature | ||
7. | ALA627593 | A | At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
8. | ALA664512 | F | Apoptotic A2780 cells after 24 hr r at 5 nM (IC50) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
9. | ALA663765 | F | Percentage A2780 cells in G1 after 24 hr r at 5 nM (IC50) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
10. | ALA663766 | F | Percentage A2780 cells in G2/M after 24 hr r at 5 nM (IC50) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
11. | ALA663767 | F | Percentage A2780 cells in S-phase after 24 hr r at 5 nM (IC50) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
12. | ALA663768 | F | Percentage A2780 cells in sub-G1 after 24 hr r at 5 nM (IC50) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
13. | ALA663771 | F | Percentage A2780 cells in G1 after 24 hr r at 29 nM (IC90) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
14. | ALA663772 | F | Percentage A2780 cells in G2/M after 24 hr r at 29 nM (IC90) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
15. | ALA663773 | F | Percentage A2780 cells in S-phase after 24 hr r at 29 nM (IC90) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
16. | ALA663774 | F | Apoptotic A2780 cells after 24 hr r at 29 nM (IC90) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
17. | ALA663775 | F | Percentage A2780 cells in sub-G1 after 24 hr r at 2 nM (IC90) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
18. | ALA666600 | B | Inhibitory activity against baculovirus expressed Cyclin dependent kinase 1-cyclinB | 19 | protein complex format | Scientific Literature | |||
19. | ALA666605 | B | Inhibitory activity against baculovirus expressed Cyclin dependent kinase 2-cyclinE | 55 | protein complex format | Scientific Literature | |||
20. | ALA666606 | B | Inhibitory activity against baculovirus expressed Cyclin dependent kinase 4-cyclinD1 | 22 | protein complex format | Scientific Literature |